Does Percutaneous Tibial Nerve Stimulation (PTNS) Improve Outcomes in Patients Presenting With Fecal Incontinence
- Conditions
- Fecal Incontinence
- Interventions
- Device: Posterior tibial nerve stimulation (PTNS)Device: Posterior tibial nerve stimulation
- Registration Number
- NCT01274585
- Lead Sponsor
- Massachusetts General Hospital
- Brief Summary
The primary objective of this study is to determine whether Percutaneous Tibial Nerve Stimulation (PTNS), a minimally invasive, simple, cost effective, and outpatient treatment of patients with urinary incontinence, can also be used to treat fecal incontinence. Specifically, the primary endpoint of this study is to determine, in a randomized controlled patient blinded study, whether PTNS decrease the episodes of fecal incontinence by 50% in the patients treated with PTNS when compared to placebo as documented by a 2 week patient bowel diary after treatment.
The investigators secondary endpoints will consist of measurements of the impact of PTNS on the severity of incontinence (defined as a decrease in the mean Fecal Incontinence Severity Index (FISI) score ), as well as on the patient quality of life factors related to fecal incontinence (defined as a decrease in the mean Fecal Incontinence Quality of Life (FIQoL) scale).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 5
- 18 years or older
- Able to provide informed consent
- Has severe fecal incontinence (defined as weekly episodes of incontinence of mucus, liquid or solid stool)
- Available to present for weekly treatments
- Available for follow-up at 3, 6, and 12 months
- Severe cardiopulmonary disease
- Lesion of the Tibial Nerve
- Use of a cardiac pacemaker or implantable defibrillator
- History of inflammatory bowel disease
- Active anal fissure, fistula, or abscess
- Active rectal bleeding which has not been evaluated with appropriate testing, such as colonoscopy
- Has a sphincter injury that needs sphincteroplasty
- Wants to pursue aggressive surgical therapy with a colostomy or an artificial bowel sphincter
- Severe distal venous insufficiency
- Uncontrolled diabetes with peripheral nerve involvement
- Immunosuppression
- Pregnant or planning on becoming pregnant during treatment
- Patients prone to bleeding
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description stimulation/treatment Posterior tibial nerve stimulation (PTNS) - No active treatment Posterior tibial nerve stimulation -
- Primary Outcome Measures
Name Time Method Frequency of Fecal Incontinence Diary kept for 14 days following treatment Patient kept 2 week bowel diary after completion of treatment. Bowel diary were collected to assess frequency of fecal incontinence in the two week span.
- Secondary Outcome Measures
Name Time Method Change in Fecal Incontinence Severity Index (FISI) Score 12 weeks Fecal Incontinence Severity Index (FISI) is a tool used to stratify severity of fecal incontinence in the subjects. The range of score is from 0 to 61 where the higher score correlates with more severe symptoms of incontinence.
Change in Fecal Incontinence Quality of Life (FIQoL) Score 12 weeks The Fecal incontinence Quality of Life (FIQoL) score evaluates how fecal incontinence impacts the subjects quality of life. The scale ranges from 37 to 159 where the higher the score, the better the quality of life associated with symptoms.
Trial Locations
- Locations (1)
Massachusetts General Hospital
🇺🇸Boston, Massachusetts, United States